A new study from researchers at Weill Cornell Medicine-Qatar (WCM-Q) reveals how the SARS-CoV-2 virus evolved from initially ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance protection against reinfection.

A Weill Cornell Medicine-Qatar study found that SARS-CoV-2 evolved from prioritizing transmission to evading immunity after the Omicron variant emerged. Before Omicron, natural immunity from prior ...

Multiple vaccine shots are needed to boost vasculitis patients’ immunity against COVID, especially if they have been treated ...

This analysis is from the healthcare payer’s perspective and in the Belgian setting, considering the Omicron variant of SARS-CoV-2. For comprehensive information, the cost-effectiveness of remdesivir ...

1 Omicron SARS-CoV-2 virus. These results show that the KP.2 vaccine offers adequate protection against emerging JN.1-lineage variants. The KP.2 vaccine can provide better boosting to the KP.2 spike ...

Certain antiviral and mAb therapies were shown to lower mortality and hospitalization rates in those infected with SARS-CoV-2 Omicron variants.

The COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, began in late 2019 in Wuhan ... As of now, India reported four cases of the Omicron sub-variant BF.7 which is a sub-lineage of the ...

DOHA: A groundbreaking study led by researchers at Weill Cornell Medicine Qatar (WCM Q) has revealed critical insights into ...